Corbion: Ilona Haaijer Steps Down as Chair, Liz Doherty to Succeed
Ilona Haaijer will resign from her position as chair of the supervisory board of Corbion effective August 1, 2026, for personal reasons. Liz Doherty, currently vice-chair, will take over until the general assembly in May 2027.
Corbion announced on Thursday, June 4, 2026, that the chair of the supervisory board, Ilona Haaijer, has informed the board she will step down from her position as chair and her role as a board member effective August 1, 2026, due to personal reasons. Haaijer explained this decision as a need to 'rebalance [her] professional and private commitments' following evolving circumstances. The board and executive team have expressed their gratitude to Ilona for her leadership, commitment, and contributions over the past six years.
Liz Doherty Ensures Continuity Until May 2027
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Liz Doherty, currently the vice-chair of the supervisory board, will assume the chairmanship until the end of her term at the general assembly in May 2027. Bob Elfring will take over as vice-chair. The supervisory board has initiated a search to fill the vacancy within its ranks.
In line with earlier guidance, Corbion experienced negative growth in both sales and earnings versus Q1 2025.
Corbion a connu une baisse des ventes et des bénéfices par rapport à l'année précédente.
Risks mentioned
Macroeconomic and geopolitical uncertainty create price and supply-chain challenges.
Negative growth in sales and earnings.
High comparable from Q1 2025 impacting results.
Opportunities identified
Sales in Health & Nutrition expected to strengthen from Q2 onwards.
Cost reduction program to deliver savings as of Q2.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
